Friday, June 18, 2021
spot_img
Array

Apollo Gleneagles Hospitals strengthens Bone Marr

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Jamshedpur, Jan. 20: Apollo Gleneagles Hospitals, Kolkata, the leader in the provision of state-of-the-art healthcare services in Eastern India, continues to expand its pioneering offerings in the domain of oncology. Strengthening its ‘Precision Oncology’ focus, the hospital, which pioneered the concept of comprehensive cancer care in the region, has expanded the ambit of its state-of-the-art Bone Marrow Transplant Unit.

Bone Marrow Transplant is a critical process which involves the replacement of damaged or destroyed bone marrow (soft fatty tissues inside the bones that produce the different kinds of blood cells) by healthy bone marrow stem cells.

While the traditional method required a matched donor (a sibling), the team at Apollo Gleneagles Hospitals, Kolkata is now undertaking haploidentical (either parent can be a donor) and even unrelated donor transplants. This latest advancement, available in only a handful of institutes across the country, helps ensure that all those in need of a transplant now have an improved chance of finding a stem cell donor.

Supported by world-class facilities including NAT-tested (nucleic acid tested) blood products, post-transplant drug level and infection monitoring, and round-the-clock multi-disciplinary care, patients can now therefore look forward to better and improved outcomes.

Dr Anupam Chakrapani, Haematologist and Haemato-Oncologist, said, “Given the cost and complexities involved, Bone Marrow Transplants were traditionally reserved for malignant conditions like Lymphoma, Leukaemia, Multiple Myeloma and some Germ Cell Tumours.

However, adoption of the latest advancements have also allowed us to extend the benefits of this advanced procedure to combat the menace of non-malignant, but none the less critical, conditions like Thalassemia and Aplastic Anaemia. Comprehensive peritransplant care facilities and a focused approach have helped improve results, even in the area of haplo- and unrelated donor transplants.”

Dr Rupali Basu, President and CEO ER, Apollo Hospitals Group, India, observed, “During 2015, about 1600 bone marrow transplants were undertaken across the nation.

Even though a large number of patients came from the eastern part of the country, a very small fraction of these procedures were undertaken in Eastern India – a fact that inspired us to strive towards addressing this gap.

Our team, supported by the latest infrastructure and best-in-class facilities, including the only NABH-certified Blood Bank in Eastern India, is therefore transforming the treatment paradigm, and consolidating our motto of ‘Touching Lives’.

We will continue to build on our services and offerings, so that patients of the region can look forward to all treatment options at the convenience of their doorstep.”

Leave a Reply

Stay Connected

5,000FansLike
2,000FollowersFollow
8,000FollowersFollow
- Advertisement -spot_img

Latest Articles